AHM Blog

Featured Post October 5, 2018

Discover the Most Valuable Data Source You’re Not Using

Are you leveraging compliance data to inform critical business decisions about your promotional spending? To improve your educational reach and cultivate deeper engagement with...

August 12, 2015

A sampling of statistics prove the point; we are in a high speed (and high intensity) age. Consider that there are five babies born every second1; that there are an estimated 20 million billion...

Read More
Disclaimer


A sampling of statistics prove the point; we are in a high speed (and high intensity) age. Consider that there are five babies born every second1; that there are an estimated 20 million billion bits of information moving around our brains every second of every day2; or that when a drug is held back from the market for any reason, it means a loss of sales. In the case of a true blockbuster drug, that could amount to $4-5 million dollars per day in lost revenue3.
No wonder we are all working and living at the speed of light trying to be leaner, faster – chasing money, power, success and a wilder, ride out of life! Don’t pause, don’t reflect. You win or lose. You’ll fall behind and fail if you stop moving. Fast at any cost is the mantra of a stressed American society today. Does anyone have time to reflect on who they are, what they are doing or more importantly why they are doing it in the first place?
What if this speed in which we live and work has consequences? Physical, mental and spiritual consequences…and yes even financial ones. Discovering one of the latest blogs from eyeforpharma, http://social.eyeforpharma.com/; “Exploring the Power of Purpose” spoke to me in many ways and addresses the need to define the WHY in which we do things as well as what makes an organization and its constituents excel.
We all are used to rolling out of bed after hitting the snooze button once or twice reciting…”time to make the donuts” with our to-do list of the day hanging over our head. Who actually thinks of the why of what they are doing? The company you work with, what is their why? Great leaders often inspire us by leading with the purpose for which they operate, their why. Author Simon Sinek’s Start with Why reviews what sets organizations apart from each other – what makes them great or, phrased a little differently, WHY are they great? And, WHY do they have loyalty from their customers?
A thought provoking question: What is your why? What is your organization’s passion for doing what it does? Does its why align with your why?
ThinkstockPhotos-186505203
Looking at the Life Sciences industry and the area in which I have spent over 18 years, I realize what gets me out of bed in the morning…my why. I recognized early on that there is a ripple effect among the stakeholders I serve. Life Sciences develop breakthrough therapies and medicines to save the lives of patients every day. Their slogans speak to their purpose: “Live to save Lives” or Pfizer’s often quoted slogan, “Working Together for a Healthier World®” Physicians spend almost a decade of post graduate study in order to understand and treat patients resulting in a healthier, more beneficial way to live. Patients seek medical care in order to live their longest, most impactful life for themselves and their loved ones.
So how does my work as a compliance and strategic solutions director expand out to these stakeholders? I believe that because we at AHM pursue solutions to remove barriers that can limit healthcare professional interactions and impede innovation, development of new modalities to treat diseases can thrive! Technology and services drive communication and collaboration amongst industry and private practice impacting patients globally – that is what we do. Why we do it: AHM remains committed to significantly investing in solutions that will “provide continuous efficiencies, enhance the customer experience, advance strategic decision making and ensure comprehensive compliance reporting to mitigate risk.” There is no one in the industry more committed to investing now and in the future to support its clients.
The good news…although we all are operating in a stressed, fast-pace environment with plenty to do and multi-tasking most of the time, our average life expectancy is on the rise at a current average of 78.8 years – so technically you may have a little bit more time to search for that why and deliver the what and the how because of your why than your ancestors before you.
So whether your WHY is personal: “You want your future bigger than your past;” or professionally driven “challenging the status quo,” the why needs to make you cry! After all, it is the WHY that leads us to the answers of who we really are.
 

1.CDC: http://www.cdc.gov/nchs/fastats/life-expectancy.htm
2.Life Expectancy 1900’s: http://demog.berkeley.edu/~andrew/1918/figure2.html
3.DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003)

 

Contributed by:


Lisa Keilty, Global VP of Compliance and Strategic Solutions, AHM

Lisa joined AHM after serving as founder of the Compliance Consulting firm PMC2 and spending over 26 years in the life sciences and meeting management industry. Leading such organizations as Pfizer, Bristol Myers Squibb and Biogen Idec through numerous international projects, financial transparency and reporting requirements, Lisa’s industry expertise has saved Life Sciences and Meeting Management organizations over 30 million dollars. As a member of the Business Development team, Lisa’s primary focus will be Thought Leadership, Demand Generation and Solution Design.

August 5, 2015

So many of the issues facing the world today demand perspective – at least in the dictionary definition of the word, namely, “a true understanding of the relative importance of things; a sense of...

Read More
Disclaimer

ThinkstockPhotos-180256577
So many of the issues facing the world today demand perspective – at least in the dictionary definition of the word, namely, “a true understanding of the relative importance of things; a sense of proportion.”When it comes to the vastly important field of medicine, regulations and guidelines are critical. A variety of structures and frameworks keep chaos at bay, regularizing treatments around accepted, clinically proven practices and delivering outstanding outcomes. These guardrails have evolved over time through regulatory agencies such as the FDA and professional organization such as the AMA, as well as through the evolution of law and practice.Sometimes, the process gets skewed. Thus, sadly, one of the most vital aspects of medical progress is now under threat; sacrificed to a well-intentioned but clumsy regulatory framework that aims to protect consumers from the presumed excesses of marketers at medical and pharmaceutical suppliers.
Because of a few seemingly egregious practices in the past that may have influenced the judgement of a small minority of medical practitioners, an entire ecosystem of vital information exchange is now clouded by suspicions and encumbered with onerous and deadening reporting requirements. Of course, the ultimate loser is the patient.
The professional events that attract practitioners encompass far more than company sponsored presentations, though company presentation are in fact extremely useful. They provide an environment for intense information exchange among practitioners. Outside of medical school, the opportunities for practitioners to spend this kind of quality time at the leading edge, sharing experiences, information, and ideas with peers, are few and far between. And they are invaluable. Sandra Raymond, CEO and president of the Lupus Foundation of America, made essentially this point in testimony to Congress when she stressed that up-to-date and detailed information is vital to patient care, especially regarding less familiar ailments and conditions.
Physician education is a vitally important cornerstone of providing great medical care, whether delivered through Continuing Medical Education (CME), office visits, or larger scale sponsored meetings, doctors thrive on abundant, quality information. Their rigorous training makes them inherently impervious to the kind of simplistic promotional strategies employed by suppliers in other industries. They are simply too smart. That’s why the public need not fear quality medical information shared through these mechanisms.
For now, the expressed desire by physicians for more and better information and for exchanges with peers has so far kept regulations from stifling this process, as explained in our AHM white paper, Promotional Programs Thriving in Open Payments. Despite the added complexities involved, physicians continue to participate in interactions with industry because they desire the education, value exchanges with their colleagues and peers, and because they have a pressing need to address key issues that their patients and their practices face.
We think the goal of ensuring practitioner objectivity is a good one. However, Congress and the regulatory community can do better. Guidelines, reasonable transparency, and above all good old fashion professionalism, are the best ways to advance medical practice and keep the lively and critical dialogue going amongst medical professionals and the enterprises that support medical advancements.
Whatever regulatory framework is devised, it needs to be clear and reasonable. Also testifying, Alan Bennett, senior counsel at Ropes & Gray and co-leader of the Medical Information Working Group, citing recent case law that could undermine the current regulations, tried to make the importance of free information clear. Bennett added, that a “patient and his or her physician should have access to the best information, for which companies are the most valuable source.”
And, whether it is in the arts, science, technology, or medicine, creativity and innovation only thrive with open communications.


Contributed by:


Lisa Keilty, Global VP of Compliance and Strategic Solutions, AHM

Lisa joined AHM after serving as founder of the Compliance Consulting firm PMC2 and spending over 26 years in the life sciences and meeting management industry. Leading such organizations as Pfizer, Bristol Myers Squibb and Biogen Idec through numerous international projects, financial transparency and reporting requirements, Lisa’s industry expertise has saved Life Sciences and Meeting Management organizations over 30 million dollars. As a member of the Business Development team, Lisa’s primary focus will be Thought Leadership, Demand Generation and Solution Design.